Abstract
This study evaluated the antioxidant activity of five resveratrol analogs by relating the activity of the molecule with its chemical structure. The five resveratrol analogs were synthesized and the antioxidant activity was evaluated using the DPPH method. The resveratrol was used as the reference standard. A descriptive statistical analysis and ANOVA followed by the Tukey test, with the aid of software. The antioxidant activity of resveratrol analogs was considered statistically different, with the analog A which showed activity superior to the others. The five analogs presented lower antioxidant activity than the reference standard (p < 0.001). According to the findings, hydroxylation was the molecular modification that gave the best evaluated antioxidant activity result. Resveratrol analogs may have an important antioxidative activity, but with the one with the higher IC50 was presented by the natural compound.
Keywords: Antioxidants, Chemical Synthesis, 2, 2-diphenyl-1-picrylhydrazyl, Hydroxylation, Resveratrol, Structure-Activity Relationship, ANOVA, analog A, IC50, Flavonoids, RNS, Alzheimer's disease, cardioprotective, anticancer, MAO-A
Letters in Drug Design & Discovery
Title: Antioxidant Activity of Resveratrol Analogs
Volume: 9 Issue: 1
Author(s): Natalia Oliveira Calil, Gustavo Senra Goncalves de Carvalho, Danielle Cristina Zimmermann Franco, Adilson David da Silva and Nadia Rezende Barbosa Raposo
Affiliation:
Keywords: Antioxidants, Chemical Synthesis, 2, 2-diphenyl-1-picrylhydrazyl, Hydroxylation, Resveratrol, Structure-Activity Relationship, ANOVA, analog A, IC50, Flavonoids, RNS, Alzheimer's disease, cardioprotective, anticancer, MAO-A
Abstract: This study evaluated the antioxidant activity of five resveratrol analogs by relating the activity of the molecule with its chemical structure. The five resveratrol analogs were synthesized and the antioxidant activity was evaluated using the DPPH method. The resveratrol was used as the reference standard. A descriptive statistical analysis and ANOVA followed by the Tukey test, with the aid of software. The antioxidant activity of resveratrol analogs was considered statistically different, with the analog A which showed activity superior to the others. The five analogs presented lower antioxidant activity than the reference standard (p < 0.001). According to the findings, hydroxylation was the molecular modification that gave the best evaluated antioxidant activity result. Resveratrol analogs may have an important antioxidative activity, but with the one with the higher IC50 was presented by the natural compound.
Export Options
About this article
Cite this article as:
Oliveira Calil Natalia, Senra Goncalves de Carvalho Gustavo, Cristina Zimmermann Franco Danielle, David da Silva Adilson and Rezende Barbosa Raposo Nadia, Antioxidant Activity of Resveratrol Analogs, Letters in Drug Design & Discovery 2012; 9 (1) . https://dx.doi.org/10.2174/157018012798192928
DOI https://dx.doi.org/10.2174/157018012798192928 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?
Current Medicinal Chemistry Prediction of Biological Activity Spectra for Substances: Evaluation on the Diverse Sets of Drug-Like Structures
Current Medicinal Chemistry Targeting the Eph System with Peptides and Peptide Conjugates
Current Drug Targets Developments in Synthesis of the Anti-inflammatory Drug, Celecoxib: A Review
Recent Patents on Inflammation & Allergy Drug Discovery Type I Interferons: Ancient Peptides with Still Under-Discovered Anti-Cancer Properties
Protein & Peptide Letters Magnetic Nanoparticles as Both Imaging Probes and Therapeutic Agents
Current Topics in Medicinal Chemistry Review of Novel Aspects of the Regulation of Ghrelin Secretion
Current Drug Metabolism Efficacy and Safety of Targeting Androgen Receptor in Advanced Breast Cancer: A Systematic Review
Current Cancer Therapy Reviews Nanoparticle Therapy for Allergic and Inflammatory Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Design, Synthesis and Antiproliferative Activity of Novel Benzothiazole Derivatives Conjugated with Semicarbazone Scaffold
Medicinal Chemistry Patent Selections
Current Biomarkers (Discontinued) Genetics of Obesity: What have we Learned?
Current Genomics Chemopreventive Properties of Tolfenamic Acid: A Mechanistic Review
Current Medicinal Chemistry The ARRONAX Project
Current Radiopharmaceuticals Regulation of the DNA Damage Response to DSBs by Post-Translational Modifications
Current Genomics RNA Interference-Based Gene Silencing in Mice: The Development of a Novel Therapeutical Strategy
Current Pharmaceutical Design Reversing Agents for ATP-Binding Cassette (ABC) Transporters: Application in Modulating Multidrug Resistance (MDR)
Current Medicinal Chemistry - Anti-Cancer Agents Pharmacological Inhibitors of Fatty Acid Synthase (FASN)-Catalyzed Endogenous Fatty Acid Biogenesis: A New Family of Anti-Cancer Agents?
Current Pharmaceutical Biotechnology Editorial (Thematic Issue: "Discovery and Development of New Anticancer Drugs Inspired from Natural Product Leads" Part 1)
Anti-Cancer Agents in Medicinal Chemistry Enteric Ecosystem Disruption in Autism Spectrum Disorder: Can the Microbiota and Macrobiota be Restored?
Current Pharmaceutical Design